The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part II

The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part II

The paper presents the main provisions of the updated 2019 EULAR/ERA-EDTA guidelines for the lupus nephritis (LN) therapy, which have been prepared by an international group of rheumatologists, nephrologists, morphologists, and pediatricians. Part 2 of the article discusses additional therapy, monit...

Full description

Bibliographic Details
Main Authors:	N. L. Kozlovskaya, S. K. Solovyev, E. A. Aseeva, T. V. Popkova, T. A. Panafidina, E. L. Nasonov, A. M. Lila, A. A. Mesnyankina, N. Yu. Nikishina
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2021-02-01
Series:	Современная ревматология
Subjects:	волчаночный нефрит клинические рекомендации
Online Access:	https://mrj.ima-press.net/mrj/article/view/1093

Similar Items

The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part I
by: N. L. Kozlovskaya, et al.
Published: (2020-11-01)

Lupus nephritis as a specific clinical and immunological phenotype of systemic lupus erythematosus
by: E. A. Aseeva, et al.
Published: (2022-12-01)

Prospects for the use of belimumab in lupus nephritis
by: N. L. Kozlovskaya, et al.
Published: (2021-08-01)

Programmed immunoadsorption with regeneration of adsoption columns in the treatment of lupus nephritis
by: A. A. Sokolov, et al.
Published: (2020-09-01)

General principles in the treatment of lupus nephritis with the prevention of cardiovascular events
by: Т. A. Panafidina, et al.
Published: (2018-12-01)

Characteristics of systemic lupus erythematosus and lupus nephritis in children in the Republic of Belarus and the Republic of Tatarstan
by: T. P. Makarova, et al.
Published: (2019-11-01)

Lupus Nephritis in Pediatric Practice: 20-Year Experience in Care
by: G. A. Makovetskaya, et al.
Published: (2021-01-01)

Clinical And Morphological Improvement Of Lupus Nephritis Treated With Rituximab
by: Tsanyan Maria E., et al.
Published: (2014-12-01)

NEWS FROM THE ANNUAL CONGRESS OF EUROPEAN SOCIETY OF CARDIOLOGY (BARCELONA 2014): REALIZED AND UNREALIZED EXPECTATIONS
by: S. Y. Martsevich, et al.
Published: (2015-09-01)

Psoriatic arthritis. Clinical guidelines for diagnosis and treatment
by: T. V. Korotaeva, et al.
Published: (2018-06-01)

REASONS FOR Β-ADRENOBLOCKER USE IN ARTERIAL HYPERTENSION: ONE MORE TIME ABOUT PRO AND CONTRA
by: V. I. Makolkin
Published: (2016-01-01)

Could evidence-based medicine results be reproduced in real-world clinical practice?
by: S. Yu. Martsevich, et al.
Published: (2008-06-01)

Clinical guidelines for the treatment of patients with vulvar squamous cell carcinoma with consideration for the FIGO (2009) and TNM (2010) classifications
by: Ye. V. Korzhevskaya, et al.
Published: (2014-07-01)

Рекомендации Американской ассоциации сердца / Американского колледжа кардиологии 2020 года по диагностике и лечению пациентов с гипертрофической кардиомиопатией: что нового?
by: С. Будагаев, et al.
Published: (2021-06-01)

GUIDELINES FOR PREPARATION OF MANUSCRIPTS DESCRIBING CLINICAL CASES IN CHILDREN: SUPPORTING THE CARE AND SCARE PRINCIPLES
by: Ruslan T. Saygitov, et al.
Published: (2017-11-01)

Practical application of national clinical guidelines for the management of gout (preliminary data)
by: M. N. Chikina, et al.
Published: (2020-05-01)

The quality of received drug therapy in patients with stable coronary heart disease according to the ALIGN (TherApy in stabLe Coronary Artery dIsease Patients According to Clinical GuideliNes) study
by: E. D. Zharkova, et al.
Published: (2022-10-01)

SEARCH FOR UNIVERSAL COMBINED ANTIHYPERTENSIVE THERAPY WITHIN LIMITED DATA ON THE COMPARATIVE EFFICACY OF ANTIHYPERTENSIVE AGENTS
by: S. R. Gilyarevskiy
Published: (2015-09-01)

ANALYSIS OF COMPLIANCE WITH THE NEW STRATEGY FOR MANAGING SEPSIS PATIENTS AND INFECTION PREVENTION DURING INTENSIVE THERAPY. RESULTS OF MULTICENTER STUDY
by: V. V. Kulabukhov, et al.
Published: (2017-11-01)

PREVENTION OF SUDDEN CARDIAC DEATH BY IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: ANALYSIS OF LARGE-SCALE CLINICAL TRIALS AND RECOMMENDATIONS OF EUROPEAN SOCIETY OF CARDIOLOGY (2015)
by: N. V. Melnik
Published: (2018-01-01)

REVIEW OF RECOMMENDATIONS FOR THE MANAGEMENT OF POLYMYALGIA RHEUMATICA (ACR/EULAR 2015)
by: M. T. Vatutin, et al.
Published: (2016-03-01)

EVALUATION OF CARDIOVASCULAR RISK FACTORS PREVALENCE AND EFFICACY OF THEIR CORRECTION IN PHYSICIANS. ESTIMATION OF PHYSICIANS’ EXPERTISE IN UP-TO-DATE CLINICAL GUIDELINES. RESULTS OF THE “PHYSICIAN’S HEALTH AND EDUCATION” STUDY
by: L. Y. Drozdova, et al.
Published: (2016-01-01)

FAMILIAL MEDITERRANEAN FEVER: THE REVIEW OF EULAR GUIDELINES, 2016
by: M. T. Vatutin, et al.
Published: (2016-12-01)

DEVELOPMENT OF CONCEPTS NOMENCLATURE FOR CLINICAL DECISION SUPPORT SYSTEM IN DIAGNOSTICS OF ANGINA PECTORIS
by: K. V. Kiselev, et al.
Published: (2018-09-01)

EVALUATION OF THE CONFORMITY OF CARDIOVASCULAR THERAPY TO CURRENT CLINICAL GUIDELINES IN THE IMPROVEMENT OF OUTCOMES IN PATIENTS AFTER STROKE (ACCORDING TO THE LIS-2 REGISTER)
by: A. Yu. Suvorov, et al.
Published: (2015-09-01)

THE WAY OF ASSESSING THE ADHERENCE TO MODERN DRUG THERAPY CLINICAL GUIDELINES AIMED AT REDUCING THE RISK OF RECURRENT STROKE (ACCORDING TO THE LIS-2 REGISTER)
by: A. Yu. Suvorov, et al.
Published: (2015-09-01)

Physicians’ assessment of the high blood pressure risk and their attitude towards the prevention of arterial hypertension
by: A. E. Manoylov
Published: (2012-12-01)

CARDIOPULMONARY RESUSCITATION IN THE PREGNANT (review of the number of clinical cases from one clinical unit)
by: А. E. Bаutin, et al.
Published: (2019-01-01)

Clinical guidelines «Children with diabetes mellitus type 1, 2020”: what a pediatrician needs to know
by: I. L. Alimova
Published: (2021-12-01)

The concept of “ambulatory” and “non-ambulatory” in patients with Duchenne muscular dystrophy: definitions and criteria
by: T. A. Gremyakova, et al.
Published: (2022-06-01)

Russian clinical practice guidelines for the management of c1 clinical class of chronic venous disorders (reticular veins and telangiectasias)
by: V. Yu. Bogachev, et al.
Published: (2021-01-01)

The Impact of the Introduction of Clinical Recommendations on Cardiology in the USA and Russia Federetionon Mortality from Ischemic Heart Diseas
by: A. A. Gerasimov
Published: (2018-09-01)

Russian clinical practice guidelines «congenital adrenal hyperplasia»
by: N. G. Mokrysheva, et al.
Published: (2021-10-01)

Acute focal bacterial nephritis
by: V. I. Kirillov, et al.
Published: (2020-01-01)

CLINICAL MANIFESTATION, DIAGNOSTICS AND TREATMENT OF ULCERATIVE COLITIS IN CHILDREN: RUSSIAN PEDIATRIC CONSENSUS
by: A. S. Potapov, et al.
Published: (2013-05-01)

Modern principles of pharmaceutical treatment in patients with chronic coronary heart disease
by: S. Yu. Martsevich
Published: (2008-06-01)

CLASSIFICATION OF DEFECTS PHARMACOTHERAPY AS THE BASIS OF QUALITY ASSESSMENT OF DRUG THERAPY IN HEALTHCARE
by: R. Kh. Khafisianova, et al.
Published: (2013-06-01)

According to the 2019 updated European League Against Rheumatism (EULAR) recommendations for the treatment of systemic lupus erythematosus: debatable issues and comments
by: T. V. Popkova, et al.
Published: (2019-11-01)

RISK FACTORS AND MARKERS OF TUBULOINTERSTITIAL NEPHRITIS DEVELOPMENT IN CHILDREN WITH OXALATE-CALCIUM CRYSTALLURIA
by: E. V. Popova, et al.
Published: (2017-09-01)

Knowledge of modern principles of rational cardiovascular therapy in Moscow primary care physicians: survey-based assessment
by: T. G. Kheliya, et al.
Published: (2012-10-01)